DE   EN   ES   FR   IT   PT


medicalmeds.eu Cardiology Prevention of a myocardial infarction

Prevention of a myocardial infarction

Contents:



Description:


Primary prevention is directed to disease prevention. It includes standard precautions, basic of which: increase in physical activity, control of body weight and refusal of addictions. Besides, normalization of arterial pressure and lipidic range of blood. For primary prevention of a heart attack at patients with stenocardia and the increased arterial pressure it is necessary to use acetylsalicylic acid (ASK) – "the gold standard" of medicinal prevention of a myocardial infarction All these actions are fair also for secondary prevention (the prevention of a repeated heart attack).
1. Control of body weight.
In each extra kilo of fatty tissue there is a set of blood vessels that sharply increases load of heart. Besides, excess weight promotes increase in arterial pressure, development of a diabetes mellitus of the second type, and, therefore, considerably increases risk. For control of weight the special indicator – a body weight index is used. For its definition weight (in kilograms) needs to be divided into growth (in meters) squared. The indicator of 20-25 kg/sq.m is normal, figures of 35-29,9 kg/sq.m speak about excess body weight, and higher than 30 – about obesity. Control of an index of body weight, certainly, takes the important place in treatment and prevention of a myocardial infarction.
2. Diet.
The diet provides existence of a large number of green vegetables, root crops, fruit, fishes, bread of a rough grinding. Red meat is replaced with fowl. Besides, it is necessary to limit amount of the consumed salt. All this enters a concept of the Mediterranean diet.
3. Exercise stresses.
Physical activity promotes decrease in body weight, lipid metabolism improvement, decrease in level of sugar of blood. The complex and level of possible loadings need to be stipulated with the doctor. Regular physical exercises reduce risk of a repeated heart attack approximately by 30%.
4. Refusal of addictions.
Smoking considerably aggravates a picture of coronary heart disease. Nicotine has vasoconstrictive effect that is extremely dangerous. The risk of a repeated myocardial infarction at smokers increases twice.
The alcohol abuse is inadmissible. It worsens the course of coronary heart disease and associated diseases. Perhaps one-time consumption of a small amount of alcohol with food. Anyway, it is necessary to discuss it with the attending physician.
5. Cholesterol level in blood.
It is defined within a lipidic range of blood (a set of indicators on which progressing of atherosclerosis depends, the main reason of coronary heart disease) and is the basic from them. Study norms of bad and good cholesterol for men and women on age. At the increased level of cholesterol the course of treatment special drugs is appointed.
6. Control of arterial pressure
The increased arterial pressure noticeably raises load of heart. Especially, it worsens the forecast after the postponed myocardial infarction. Also the hypertension promotes progressing of atherosclerosis. Level of systolic (upper) arterial pressure below 140 mm Hg is considered optimum, and diastolic (lower) – it is not higher than 90 mm Hg. Higher figures are dangerous and demand correction of the scheme of administration of drugs, lowering pressure.
7. Blood sugar level.
Existence of the dekompensirovanny (not adjusted) diabetes mellitus negatively influences on the course of coronary heart disease. It is connected with harmful action on hyperglycemia vessels (the raised blood sugar level). It is necessary to watch this indicator constantly, and at the raised sugar it is obligatory to consult with the endocrinologist for correction of the scheme of treatment.
The checked "gold standard" in medicinal prevention of coronary heart disease, myocardial infarction is acetylsalicylic acid.

Развитие инфаркта миокарда

Development of a myocardial infarction



The used drugs:

  • Препарат Аторвастерол.

    Atorvasterol

    Hypolipidemic means.

    Polpharma/Medana Pharma S. A. (Polfarm / Medan of Pharm S.A.) Poland

  • Препарат Симвастатин.

    Simvastatin

    Hypolipidemic means.

    CJSC ZIO-Zdorovye Russia

    3

  • Препарат Варфарин.

    Warfarin

    Anticoagulant of indirect action.

    RUP of Belmedpreparata Republic of Belarus

    5

  • Препарат Тромбопол®.

    Тромбопол®

    Non-steroidal anti-inflammatory drug (NPVP).

    JSC Chemical and Pharmaceutical Plant AKRIKHIN Russia

  • Препарат Полприл.

    Polpril

    The means operating on a renin-angiotenzinovuyu system. Inhibitors of an angiotensin-converting enzyme (APF).

    JSC Himfarm Republic of Kazakhstan

  • Препарат Рамилонг.

    Рамилонг

    Angiotensin-converting enzyme inhibitor (APF inhibitor).

    SOOO "Lekfarm" Republic of Belarus

  • Препарат Лоспирин.

    Lospirin

    Antitrombotichesky means.

    LLC Kusum Pharm Ukraine

  • Препарат Ацетилсалициловая кислота кардио.

    Acetylsalicylic acid cardio

    Antiagregantny means.

    CJSC FP OBOLENSKOYE Russia

  • Препарат Роксера®.

    Роксера®

    Hypolipidemic means - KOA-reductase GMG inhibitor.

    Krka Russia

  • Препарат Овенкор.

    Ovenkor

    Hypolipidemic means.

    LLC Ozon Russia

  • Препарат Метопролол.

    Metoprolol

    Beta1-adrenoblokator the selection.

    JSC Biokhimik Republic of Mordovia

    1

  • Препарат Варфарин Орион.

    Orion warfarin

    Antitrombotichesky means. Antagonists of vitamin K.

    Orion Pharma (Orion of Pharm) Finland

  • Препарат Метопролол-Акри®.

    Метопролол-Акри®

    The selection beta1-adrenoblocker.

    JSC Chemical and Pharmaceutical Plant AKRIKHIN Russia

    4

  • Препарат Полаприл.

    Polapril

    Angioteningibitor of an angiotensin-converting enzyme (APF inhibitor).

    Polpharma/Medana Pharma S. A. (Polfarm / Medan of Pharm S.A.) Poland

  • Препарат Омекорд-МИК.

    Omekord-Mick

    Hypolipidemic drugs.

    Minskinterkaps Unitary Enterprise Republic of Belarus

  • Препарат Атенолол.

    Atenolol

    Anti-hypertensive and anti-anginal means. Cardioselective beta1-adrenoblocker.

    LLC Pharmlend Republic of Belarus

  • Препарат Обзидан.

    Obsidanum

    Beta adrenoblocker.

    Actavis Ltd. (Aktavis Ltd.) Switzerland

  • Препарат Симвастатин.

    Simvastatin

    Hypolipidemic means - KOA-reductase GMG inhibitor.

    CJSC Verteks Russia

  • Препарат Варфарин.

    Warfarin

    Anticoagulating means.

    LLC Ozon Russia

  • Препарат Таспир.

    Taspir

    Non-steroidal anti-inflammatory drug (NPVP).

    JSC Tatkhimfarmpreparaty Russia


  • Сайт детского здоровья